Enovis (ENOV) vs Hyperfine (HYPR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Enovis (ENOV) has outperformed Hyperfine (HYPR) over the past year, losing 45.2% versus a loss of 55.0%. Over five years, ENOV leads with a -80.0% price change compared with -90.5% for HYPR. Enovis is the larger company by market cap ($1.01 billion vs $99.7 million), about 10.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ENOV | HYPR |
|---|---|---|
| Share price | $17.43 | $0.9401 |
| Market cap | $1.01B | $99.70M |
| 1-day change | -1.02% | +10.73% |
| YTD return | -34.57% | -3.97% |
| 1-year return | -45.15% | -55.02% |
| 5-year return | -79.99% | -90.54% |
| Forward P/E | 4.85 | — |
| EPS (TTM) | $-19.23 | $-0.37 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $34.28 | $2.22 |
| 52-week low | $16.70 | $0.754 |
| Distance from 52-week high | -49.15% | -57.65% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +115.61% | +115.93% |
| Average volume | 1.46M | 765.15K |
| Shares outstanding | 57.67M | 90.99M |
| Employees | 7,802 | 102 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Enovis is about 10.1 times larger than Hyperfine by market value ($1.01B vs $99.70M).
About Enovis
ENOV stock →Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments.
Health Care · Industrial Specialties · 7,802 employees
About Hyperfine
HYPR stock →Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 102 employees
ENOV vs HYPR FAQ
Which is bigger, Enovis or Hyperfine?
Enovis (ENOV) is larger, with a market capitalization of $1.01B compared with $99.70M for Hyperfine (HYPR).
Which stock has performed better over the past year, ENOV or HYPR?
ENOV returned -45.15% over the past 12 months, compared with -55.02% for HYPR (price return, excluding dividends). Past performance does not predict future results.
Are Enovis and Hyperfine in the same industry?
Both are in the Health Care sector, but in different industries: Industrial Specialties for Enovis and Biotechnology: Electromedical & Electrotherapeutic Apparatus for Hyperfine.